Allogeneic Thymocyte-Depleted Thymus Tissue-Agdc: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Allogeneic Thymocyte-Depleted Thymus Tissue-Agdc. Educational only — not medical advice.
Labeled uses
RETHYMIC® is indicated for immune reconstitution in pediatric patients with congenital athymia.
Source: FDA labeling via NIH DailyMed (set e0022c28…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.